AVGR:NSD-Avinger Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | NSD

Last Closing Price

USD 0.28

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

2.02M

Avg Analyst Target

USD 2.00 (+611.24%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Avinger Inc (AVGR) Stock Analysis:
Based on the Avinger Inc stock forecasts from 1 analysts, the average analyst target price for Avinger Inc is USD 2.00 over the next 12 months. Avinger Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Avinger Inc is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Avinger Inc’s stock price was USD 0.28. Avinger Inc’s stock price has changed by -0.03% over the past week, -0.26% over the past month and -86.80% over the last year.

About

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular plat ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-23 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG Intuitive Surgical Inc

N/A

USD95.81B 57.55 56.84
HOLX Hologic Inc

N/A

USD17.76B 9.80 7.26
MASI Masimo Corporation

N/A

USD12.03B 54.19 49.11
XRAY DENTSPLY SIRONA Inc

N/A

USD11.57B 27.83 14.28
RGEN Repligen Corporation

N/A

USD10.16B 87.49 73.96
NVCR NovoCure Limited

N/A

USD6.97B 1,480.87 4,066.85
AZTA Azenta Inc

N/A

USD5.82B 52.30 406.97
ICUI ICU Medical Inc

N/A

USD5.05B 42.28 18.69
STAA STAAR Surgical Company

N/A

USD3.41B 152.58 123.68
MMSI Merit Medical Systems Inc

N/A

USD3.14B 72.72 25.40

ETFs Containing AVGR

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -37.51% 3% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.51% 3% F 4% F
Trailing 12 Months  
Capital Gain -86.80% 3% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.80% 3% F 3% F
Trailing 5 Years  
Capital Gain -99.97% 4% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.97% 4% F N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -20.83% 6% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.83% 6% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 112.79% 19% F 13% F
Risk Adjusted Return -18.47% 6% F 17% F
Market Capitalization 0.03B 3% F 7% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 0.09 100% A+ 94% A
Price/Book Ratio 4.54 41% F 27% F
Price / Cash Flow Ratio -1.81 56% F 59% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -131.02% 11% F 9% F
Return on Invested Capital -83.02% 11% F 10% F
Return on Assets -31.44% 6% F 11% F
Debt to Equity Ratio 71.89% 24% F 29% F
Technical Ratios  
Short Ratio 0.72 92% A- 80% B-
Short Percent 0.83% 89% B+ 75% C
Beta 1.59 29% F 22% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector